David Mountcastle Sells 3,933 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CFO David Mountcastle sold 3,933 shares of the stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total value of $69,889.41. Following the completion of the sale, the chief financial officer now directly owns 262,279 shares in the company, valued at $4,660,697.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA traded up $0.13 during midday trading on Thursday, reaching $18.38. The company had a trading volume of 762,029 shares, compared to its average volume of 984,527. Privia Health Group, Inc. has a 1-year low of $17.54 and a 1-year high of $30.15. The firm has a market cap of $2.18 billion, a price-to-earnings ratio of 96.74, a price-to-earnings-growth ratio of 2.47 and a beta of 0.81. The company has a fifty day simple moving average of $20.59 and a two-hundred day simple moving average of $21.71.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by ($0.02). Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The company had revenue of $440.80 million during the quarter, compared to analyst estimates of $425.81 million. During the same quarter last year, the business earned $0.14 EPS. The company's revenue for the quarter was up 21.0% compared to the same quarter last year. Analysts expect that Privia Health Group, Inc. will post 0.26 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on PRVA shares. JPMorgan Chase & Co. dropped their target price on Privia Health Group from $38.00 to $30.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 6th. Jefferies Financial Group started coverage on Privia Health Group in a research report on Monday, February 26th. They issued a "buy" rating and a $25.00 target price on the stock. Bank of America lowered Privia Health Group from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $27.00 to $21.00 in a research report on Thursday, February 22nd. Evercore ISI lowered their price target on Privia Health Group from $26.00 to $25.00 and set an "outperform" rating on the stock in a report on Wednesday, February 28th. Finally, Barclays started coverage on Privia Health Group in a report on Wednesday, March 6th. They set an "equal weight" rating and a $22.00 price target on the stock. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Privia Health Group currently has an average rating of "Moderate Buy" and an average target price of $28.58.

Institutional Investors Weigh In On Privia Health Group

Several hedge funds have recently bought and sold shares of the business. BlackRock Inc. lifted its stake in Privia Health Group by 201.7% in the 2nd quarter. BlackRock Inc. now owns 13,938,867 shares of the company's stock worth $363,944,000 after acquiring an additional 9,319,052 shares in the last quarter. Vanguard Group Inc. lifted its stake in Privia Health Group by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company's stock worth $259,740,000 after acquiring an additional 274,345 shares in the last quarter. Wellington Management Group LLP lifted its stake in Privia Health Group by 1.0% in the 3rd quarter. Wellington Management Group LLP now owns 4,656,685 shares of the company's stock worth $107,104,000 after acquiring an additional 45,639 shares in the last quarter. Riverbridge Partners LLC lifted its stake in Privia Health Group by 8.2% in the 4th quarter. Riverbridge Partners LLC now owns 4,595,358 shares of the company's stock worth $105,831,000 after acquiring an additional 348,328 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Privia Health Group by 1.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 4,040,027 shares of the company's stock worth $92,921,000 after acquiring an additional 62,543 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.